Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Ganoderma lucidum may help treat enlarged prostate in rats.

Hormonal interactions, especially involving DHT and estrogen, play a key role in BPH development and treatment.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

The document concludes that it's important to understand the placebo effect when evaluating the effectiveness of treatments in medical trials.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

Adding cerium(III) chloride to Grignard reagents improves the making of compounds that could treat prostate issues and hair loss.

Finding new uses for existing drugs is promising and can lead to safer, more effective medicines.

Men with depression and marijuana usage are more likely to be treated for lower urinary tract symptoms/benign prostatic hyperplasia.

BPH medications may increase the risk of self-harm and depression, especially in the first 18 months.

Finasteride for hair loss may increase the risk of certain cancers and has side effects; better regulation and education on its use are needed.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

Finasteride may cause lasting sexual and mental health issues, and genetic screening could help prevent them.

Entadfi, a mix of finasteride and tadalafil, is used for BPH.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

Boron/nitrogen-doped carbon nano-onions improve targeted breast cancer treatment by enhancing drug delivery and reducing side effects.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Ganoderma lucidum, a type of mushroom, may help treat enlarged prostate by blocking testosterone conversion.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Finasteride affects urinary steroid profiles and can potentially hide steroid abuse in sports drug testing.

Early hair loss may indicate prostate issues.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Finasteride can cause enlarged breasts.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Finasteride doesn't affect oral testosterone undecanoate, and high DHT levels may cause acne, prostate issues, and hair loss.

Early hair loss may indicate future prostate issues.

Stopping tamsulosin one month before cataract surgery reduces eye surgery complications in rats.

Taking finasteride before surgery reduces blood loss in prostate procedures.